BluGlass Completes AUS$8m Placement to Scale GaN Laser Operations

BluGlass Ltd, an optoelectronics manufacturer based in Silverwater, Australia, has successfully completed an upsized two-tranche placement to raise approximately AUS$8 million before costs. The company, which specializes in gallium nitride (GaN) visible laser diodes using proprietary low-temperature, low-hydrogen remote-plasma chemical vapor deposition technology, received strong investor commitments at an issue price of AUS$0.24 per share.

The placement includes one free attaching option for every share subscribed, exercisable at AUS$0.38 and expiring on 31 May 2028. Notably, BluGlass' board and management demonstrated confidence in the company's future by committing AUS$2.3 million to the raise, with executive chair Omer Granit personally investing AUS$2 million. Board participation and option issuance remain subject to shareholder approval at an extraordinary general meeting scheduled for approximately 25 May.

The capital raised will be strategically deployed to scale BluGlass' GaN laser operations, acquire additional fabrication equipment, and support new and existing customer contracts. Executive chair Omer Granit emphasized that the strong investor demand reflects the company's operational momentum, noting that BluGlass has recently secured almost US$3 million in development contracts and orders.

Granit highlighted the company's significant project pipeline exceeding US$100 million and emphasized BluGlass' strategic positioning in the global marketplace. He stated that the board and management's participation reinforces confidence in the company's GaN laser technology, growing addressable market, and long-term growth potential. According to Granit, lasers represent critical components for all next-generation technologies, and BluGlass is well-positioned to capture market share as GaN laser adoption accelerates exponentially.

CEO and executive director Jim Haden noted that BluGlass has achieved a strong start to the calendar year with momentum building across multiple target verticals. The company's growing customer base includes the US Department of War, the Indian Ministry of Defence, tier-1 defence primes, and Fortune 500 technology companies. Haden emphasized BluGlass' unique position as one of only two GaN laser suppliers with US manufacturing facilities, an increasingly important advantage as governments prioritize onshoring critical manufacturing capabilities.

The placement structure comprises two tranches: Tranche 1 will raise AUS$5.6 million before costs through the issuance of approximately 23.5 million shares, to be allotted on 17 April, utilizing the company's placement capacity under ASX Listing Rules 7.1 and 7.1A. Tranche 2 will raise AUS$2.4 million before costs through the issuance of 10.1 million shares to certain investors including board and management, to be allotted on or around 28 May.

The issue price of AUS$0.24 represents a 7% discount to the 15-day volume-weighted average price, a 9% discount to the 5-day volume-weighted average price, and a 2% discount to the last traded price, offering reasonable terms to investors while benefiting existing shareholders.

Additionally, executive chair Omer Granit has entered into an interim executive services agreement with BluGlass, with an initial term ending on 30 April. Under this agreement, Granit is entitled to total remuneration of US$25,000 per month as executive chair. The company has already paid Granit US$75,000 for the period from 1 January to 31 March. The board is currently considering independent specialist remuneration advice and expects to finalize Granit's ongoing remuneration structure in the coming weeks.